| 1 |
Igna R, Gîrleanu I, Cojocariu C, Huiban L, Muzîca C, Sîngeap AM, Sfarti C, Chiriac S, Petrea OC, Zenovia S, Nastasa R, Cuciureanu T, Stafie R, Stratina E, Rotaru A, Stanciu C, Blaj M, Trifan A. The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure. J Clin Med 2022;11. [PMID: 36143057 DOI: 10.3390/jcm11185410] [Reference Citation Analysis]
|
| 2 |
Igna R, Gîrleanu I, Cojocariu C, Muzîca C, Huiban L, Sfarti C, Cuciureanu T, Chiriac S, Sîngeap AM, Petrea OC, Stafie R, Zenovia S, Năstasă R, Stratina E, Rotaru A, Stanciu C, Trifan A, Blaj M. The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy. Diagnostics (Basel) 2022;12. [PMID: 36140479 DOI: 10.3390/diagnostics12092077] [Reference Citation Analysis]
|
| 3 |
Tornai D, Vitalis Z, Jonas A, Janka T, Foldi I, Tornai T, Sipeki N, Csillag A, Balogh B, Sumegi A, Foldesi R, Papp M, Antal-Szalmas P. Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality. Clin Res Hepatol Gastroenterol 2021;45:101579. [PMID: 33773436 DOI: 10.1016/j.clinre.2020.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Ferrarese A, Plebani M, Frigo AC, Burra P, Senzolo M. Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease. J Hepatol 2021;75:232-4. [PMID: 33484772 DOI: 10.1016/j.jhep.2021.01.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Zhang Z, Ma K, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Zhang M, Luo X, Chen T, Ning Q. Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infect Dis Ther 2021;10:1347-61. [PMID: 33991329 DOI: 10.1007/s40121-021-00454-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Gavrilenko DI, Silivontchik N. Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers. CMAC 2021;23:147-160. [DOI: 10.36488/cmac.2021.2.147-160] [Reference Citation Analysis]
|
| 7 |
Ferrarese A, Frigo AC, Mion MM, Plebani M, Russo FP, Germani G, Gambato M, Cillo U, Cattelan A, Burra P, Senzolo M. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection. Clin Chem Lab Med 2020:cclm-2020-1212. [PMID: 33095752 DOI: 10.1515/cclm-2020-1212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Haurylenka DI, Republican Research Centre for Radiation Medicine and Human Ecology, Gomel, Belarus, Silivontchik NN, Belarusian Medical Academy of Post-Graduate Education, Minsk, Belarus. TRANSLOCATION OF INTESTINAL MICROFLORA IN CIRRHOSIS. Hepatol and Gastroenterol 2020;4:143-150. [DOI: 10.25298/2616-5546-2020-4-2-143-150] [Reference Citation Analysis]
|
| 9 |
Fischer P, Grigoras C, Bugariu A, Nicoara-Farcau O, Stefanescu H, Benea A, Hadade A, Margarit S, Sparchez Z, Tantau M, Ionescu D, Procopet B. Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis? Dig Liver Dis 2019;51:1685-91. [PMID: 31221548 DOI: 10.1016/j.dld.2019.05.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Elefsiniotis I, Tsakiris SA, Barla G, Tasovasili A, Vrachatis D, Mavrogiannis C. Presepsin levels in cirrhotic patients with bacterial infections and/or portal hypertension-related bleeding, presenting with or without acute kidney injury. Ann Gastroenterol 2018;31:604-12. [PMID: 30174398 DOI: 10.20524/aog.2018.0292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 11 |
Palyu E, Harsfalvi J, Tornai T, Papp M, Udvardy M, Szekeres-Csiki K, Pataki L, Vanhoorelbeke K, Feys HB, Deckmyn H, Tornai I. Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation. Thromb Haemost 2018;118:1397-408. [PMID: 29972862 DOI: 10.1055/s-0038-1661393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 12 |
El Gendy FM, El-Mekkawy MS, Saleh NY, Habib MSE, Younis FE. Clinical study of Presepsin and Pentraxin3 in critically ill children. J Crit Care 2018;47:36-40. [PMID: 29886065 DOI: 10.1016/j.jcrc.2018.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 13 |
Piotrowski D, Boroń-Kaczmarska A. Bacterial infections and hepatic encephalopathy in liver cirrhosis-prophylaxis and treatment. Adv Med Sci 2017;62:345-56. [PMID: 28514703 DOI: 10.1016/j.advms.2016.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Shiota J, Tagawa H, Ohura N, Kasahara H. Presepsin is a potent biomarker for diagnosing skin wound infection in hemodialysis patients compared to white blood cell count, high-sensitivity C-reactive protein, procalcitonin, and soluble CD14. Ren Replace Ther 2017;3. [DOI: 10.1186/s41100-017-0113-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
